Review on various Pharmaceuticals and their Pharmacology of Anti-repellents- As a Preventive aspect of Vector (mosquito species) borne Disease

Abstract

Mosquito is one of the most vexing bloodsucking insects. Malaria, Filariasis, Japanese Encephalitis, Dengue fever, Yellow fever, Chikungunya, and Zika are all transmitted by mosquito species belonging to the genera Anopheles, Culex, & Aedes. Mosquitoes alone infect almost 700 million people each year, resulting in one million fatalities. Malaria, which is caused by Plasmodium parasites and transmitted by female Anopheles mosquito bites, is still a substantial illness that impacts the development of infants and kids. Present review work aims to review various pharmaceutical dosage forms of anti-repellent products and their molecules, mechanism of repellent activity as a preventive of different vector bone diseases. Malaria cases were over 207 million in 2012, with 627,000 deaths reported. In addition, Yellow fever, which is spread by the Haematologus and Aedes mosquitoes, causes 200,000 instances of disease and 30,000 fatalities worldwide each year. Dengue fever is spread by Aedes aegypti and Aedes albopictus mosquitos, which are responsible for more than 100 million infections yearly. Furthermore, more than 2.5 billion individuals, or about 40% of the world's population, are now in danger of contracting Dengue fever. This review helped to understand the various kinds of vector bone disease and the surveillance of disease data. In addition, the review revealed the various pharmaceutical products would help control the Mosquitoes bits and related disease as preventive aspects and the components of pharmaceutical and their mechanism of action to inhibit the spread of various insects’ related disease.